Sandrine Vanmarcke

Journal Article
A1
open access

Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline : caution is warranted

Delphine Diana Acar, Wojciech Witkowski (UGent) , Magdalena Wejda (UGent) , Ruifang Wei (UGent) , Tim Desmet (UGent) , Bert Schepens (UGent) , Sieglinde De Cae (UGent) , Koen Sedeyn (UGent) , Hannah Eeckhaut (UGent) , Daria Fijalkowska (UGent) , et al.

(2024) EBIOMEDICINE. 100.

Add to list

Journal Article
A1
open access

OPENPichia : licence-free Komagataella phaffii chassis strains and toolkit for protein expression

Katrien Claes (UGent) , Dries Van Herpe (UGent) , Robin Vanluchene, Charlotte Roels (UGent) , Berre Van Moer (UGent) , Elise Wyseure (UGent) , Kristof Vandewalle, Hannah Eeckhaut (UGent) , Semiramis Yilmaz (UGent) , Sandrine Vanmarcke (UGent) , et al.

(2024) NATURE MICROBIOLOGY. 9(3). p.864-876

Add to list

Journal Article
A1
open access

GlycoVHH : optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery

Loes van Schie (UGent) , Wander Van Breedam (UGent) , Charlotte Roels (UGent) , Bert Schepens (UGent) , Martin Frank, Ahmadreza Mehdipour (UGent) , Bram Laukens, Wim Nerinckx (UGent) , Francis Santens, Simon Devos (UGent) , et al.

(2023) MABS. 15(1).

Add to list

Miscellaneous

GlycoVHH : introducing N-glycans on the camelid VHH antibody scaffold : optimal sites and use for macrophage delivery

Loes van Schie (UGent) , Wander Van Breedam (UGent) , Charlotte Roels (UGent) , Bert Schepens (UGent) , Martin Frank, Ahmadreza Mehdipour (UGent) , Bram Laukens, Wim Nerinckx (UGent) , Francis Santens, Simon Devos (UGent) , et al.

(2022) BioRXiv.

Add to list

GlyConnect-Ugi : site-selective, multi-component glycoprotein conjugations through GlycoDelete expressed glycans

Karel Thooft, Wander Van Breedam (UGent) , Francis Santens, Elise Wyseure (UGent) , Sandrine Vanmarcke (UGent) , Simon Devos (UGent) , Nico Callewaert (UGent) and Annemieke Madder (UGent)

(2022) ORGANIC & BIOMOLECULAR CHEMISTRY. 20(2). p.464-471

Add to list

Journal Article
A1
open access

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models

Bert Schepens (UGent) , Loes van Schie (UGent) , Wim Nerinckx (UGent) , Kenny Roose (UGent) , Wander Van Breedam (UGent) , Daria Fijalkowska (UGent) , Simon Devos (UGent) , Wannes Weyts (UGent) , Sieglinde De Cae (UGent) , Sandrine Vanmarcke (UGent) , et al.

(2021) SCIENCE TRANSLATIONAL MEDICINE. 13(621).

Add to list

Journal Article
A1
open access

Development of a counterselectable transposon to create markerless knockouts from an 18,432-clone ordered Mycobacterium bovis bacillus Calmette-Guérin mutant resource

Katlyn Borgers, Kristof Vandewalle, Annelies Van Hecke (UGent) , Gitte Michielsen (UGent) , Evelyn Plets (UGent) , Loes van Schie (UGent) , Sandrine Vanmarcke (UGent) , Laurent Schindfessel (UGent) , Nele Festjens (UGent) and Nico Callewaert (UGent)

(2020) MSYSTEMS. 5(4).

Academic Bibliography

Sandrine Vanmarcke

Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline : caution is warranted

OPENPichia : licence-free Komagataella phaffii chassis strains and toolkit for protein expression

GlycoVHH : optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery

GlycoVHH : introducing N-glycans on the camelid VHH antibody scaffold : optimal sites and use for macrophage delivery

GlyConnect-Ugi : site-selective, multi-component glycoprotein conjugations through GlycoDelete expressed glycans

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models

Development of a counterselectable transposon to create markerless knockouts from an 18,432-clone ordered Mycobacterium bovis bacillus Calmette-Guérin mutant resource

Contents

Support

Contact